M. Mohammadi‐Khanaposhtani

发表

Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Dan J Stein, T. H. Nguyen, Ravi Prakash Jha, 2019, The Lancet Neurology.

Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Eyal Oren, Mohammad Hosein Farzaei, Fares Alahdab, 2017, The Lancet. Neurology.

Synthesis of highly functionalized organic compounds through Ugi post-transformations started from propiolic acids

B. Larijani, M. Mahdavi, M. Mohammadi‐Khanaposhtani, 2019, Molecular Diversity.

Design, synthesis, in vitro cytotoxic activity evaluation, and apoptosis-induction study of new 9(10H)-acridinone-1,2,3-triazoles

A. Shafiee, A. Foroumadi, M. Mahdavi, 2015, Molecular Diversity.

A review on synthesis, mechanism of action, and structure-activity relationships of 1,2,3-triazole-based α-glucosidase inhibitors as promising anti-diabetic agents

B. Larijani, M. Faramarzi, Zari Fallah, 2022, Journal of Molecular Structure.

Design, Synthesis and In vitro Cytotoxicity of New 1,2,3-triazol- and Nitrostyrene Hybrids as Potent Anticancer Agents

B. Larijani, M. Mehrdad, M. Ardestani, 2018, Letters in Drug Design & Discovery.

Synthesis, in vitro and in silico enzymatic inhibition assays, and toxicity evaluations of new 4,5-diphenylimidazole-N-phenylacetamide derivatives as potent α-glucosidase inhibitors

B. Larijani, H. Rastegar, M. Faramarzi, 2021, Medicinal Chemistry Research.

Design, Synthesis, and Biological Evaluation of New Indole-Acrylamide-1,2,3-Triazole Derivatives as Potential α-Glucosidase Inhibitors

B. Larijani, M. Faramarzi, A. Foroumadi, 2020, Polycyclic Aromatic Compounds.

New phthalimide-benzamide-1,2,3-triazole hybrids; design, synthesis, α-glucosidase inhibition assay, and docking study

B. Larijani, M. Mahdavi, M. Mohammadi‐Khanaposhtani, 2020, Medicinal Chemistry Research.

Synthesis, molecular dynamic, and in silico study of new ethyl 4-arylpyrimido[1,2-b]indazole-2-carboxylate: Potential inhibitors of α-glucosidase

B. Larijani, H. Rastegar, M. Faramarzi, 2022, Journal of Molecular Structure.

Synthesis and biological evaluation of new dihydroindolizino[8,7-b]indole derivatives as novel α-glucosidase inhibitors

B. Larijani, A. Moghadamnia, M. Faramarzi, 2021 .

Design, synthesis, in vitro, and in silico studies of novel diarylimidazole-1,2,3-triazole hybrids as potent α-glucosidase inhibitors.

B. Larijani, M. Faramarzi, M. Asgari, 2019, Bioorganic & medicinal chemistry.

Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors.

B. Larijani, M. Faramarzi, M. Mahdavi, 2019, Bioorganic chemistry.

Docking study, molecular dynamic, synthesis, anti-α-glucosidase assessment, and ADMET prediction of new benzimidazole-Schiff base derivatives

B. Larijani, H. Adibi, H. Rastegar, 2022, Scientific reports.

Design, synthesis, in vitro α-glucosidase inhibition, docking, and molecular dynamics of new phthalimide-benzenesulfonamide hybrids for targeting type 2 diabetes

B. Larijani, M. Faramarzi, M. Adib, 2022, Scientific Reports.

Design, synthesis and biological evaluation of novel phthalimide-Schiff base-coumarin hybrids as potent α-glucosidase inhibitors

B. Larijani, M. Faramarzi, M. Asgari, 2020, Chemical Papers.

Design, synthesis, biological evaluation, and docking study of new acridine‐9‐carboxamide linked to 1,2,3‐triazole derivatives as antidiabetic agents targeting α‐glucosidase

B. Larijani, H. Rastegar, M. Faramarzi, 2020 .

Novel quinazolin–sulfonamid derivatives: synthesis, characterization, biological evaluation, and molecular docking studies

I. Gulcin, B. Larijani, P. Taslimi, 2020, Journal of Biomolecular Structure and Dynamics.

Synthesis, characterization, molecular docking, and biological activities of coumarin–1,2,3‐triazole‐acetamide hybrid derivatives

I. Gulcin, B. Larijani, P. Taslimi, 2020, Archiv der Pharmazie.

Design, synthesis, in vitro and in silico biological assays of new quinazolinone-2-thio-metronidazole derivatives

B. Larijani, P. Taslimi, M. Asgari, 2021 .

Design, synthesis, in vitro, and in silico biological evaluations of coumarin-indole hybrids as new anti-α-glucosidase agents

H. Rastegar, M. Faramarzi, M. Mohammadi‐Khanaposhtani, 2022, BMC Chemistry.

Design, synthesis, and α‐glucosidase‐inhibitory activity of phenoxy‐biscoumarin–N‐phenylacetamide hybrids

B. Larijani, H. Rastegar, M. Faramarzi, 2021, Archiv der Pharmazie.

Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017

Madhu Sudhan Atteraya, Mohammad Hosein Farzaei, Fares Alahdab, 2018, The Lancet.

Design, synthesis, and evaluation of novel racecadotril-tetrazole-amino acid derivatives as new potent analgesic agents

M. Mohammadi‐Khanaposhtani, A. Dehpour, M. Amanlou, 2021, Research in pharmaceutical sciences.

New thiosemicarbazide-1,2,3-triazole hybrids as potent α-glucosidase inhibitors: Design, synthesis, and biological evaluation

B. Larijani, A. Fassihi, L. Saghaie, 2019, Journal of Molecular Structure.

Design and synthesis of new imidazo[1,2-b]pyrazole derivatives, in vitro α-glucosidase inhibition, kinetic and docking studies

B. Larijani, H. Rastegar, A. Moghadamnia, 2019, Molecular Diversity.

Quinazolinone-dihydropyrano[3,2-b]pyran hybrids as new α-glucosidase inhibitors: Design, synthesis, enzymatic inhibition, docking study and prediction of pharmacokinetic.

B. Larijani, H. Rastegar, M. Mahdavi, 2021, Bioorganic chemistry.

Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano[3,2-c]quinoline derivatives as potential anti-diabetic agents.

B. Larijani, M. Faramarzi, M. Mahdavi, 2018, Bioorganic chemistry.

Novel spiro[indene‐1,2′‐quinazolin]‐4′(3′H)‐one derivatives as potent anticonvulsant agents: One‐pot synthesis, in vivo biological evaluation, and molecular docking studies

M. Mahdavi, M. Mohammadi‐Khanaposhtani, A. Mohammadi, 2022, Journal of biochemical and molecular toxicology.

Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.

Reza Ghadimi, B. Larijani, H. Rastegar, 2019, Bioorganic chemistry.

Design, synthesis, in vivo, and in silico evaluation of new coumarin-1,2,4-oxadiazole hybrids as anticonvulsant agents.

M. Mohammadi‐Khanaposhtani, N. Ahangar, Mina Saeedi, 2019, Bioorganic chemistry.

Design, synthesis, pharmacological evaluation, and docking study of new acridone-based 1,2,4-oxadiazoles as potential anticonvulsant agents.

A. Shafiee, A. Foroumadi, M. Shabani, 2016, European journal of medicinal chemistry.

New acridine-9-carboxamide linked to 1,2,3-triazole-N-phenylacetamide derivatives as potent α-glucosidase inhibitors: design, synthesis, in vitro, and in silico biological evaluations

B. Larijani, M. Faramarzi, M. Adib, 2020, Medicinal Chemistry Research.

Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti‐Alzheimer's agents

A. Foroumadi, A. Asadipour, A. Abiri, 2019, Archiv der Pharmazie.

New ciprofloxacin–dithiocarbamate–benzyl hybrids: design, synthesis, antibacterial evaluation, and molecular modeling studies

B. Larijani, M. Amini, M. Faramarzi, 2018, Research on Chemical Intermediates.

Novel cinnamic acid–tryptamine hybrids as potent butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study

B. Larijani, M. Amini, N. Edraki, 2018, Archiv der Pharmazie.

Design, synthesis, molecular modeling and anticholinesterase activity of benzylidene-benzofuran-3-ones containing cyclic amine side chain.

M. Sharifzadeh, A. Foroumadi, Alireza Moradi, 2017, Future medicinal chemistry.

New quinoxalin‐1,3,4‐oxadiazole derivatives: Synthesis, characterization, in vitro biological evaluations, and molecular modeling studies

I. Gulcin, B. Larijani, H. Rastegar, 2021, Archiv der Pharmazie.

Sulfonamide-phosphonate hybrids as new carbonic anhydrase inhibitors: In vitro enzymatic inhibition, molecular modeling, and ADMET prediction

S. Zareei, P. Taslimi, M. Adib, 2022, Journal of Molecular Structure.

New Biscoumarin Derivatives as Potent α-Glucosidase Inhibitors: Synthesis, Biological Evaluation, Kinetic Analysis, and Docking Study

B. Larijani, H. Adibi, A. Foroumadi, 2018, Polycyclic Aromatic Compounds.

Design, synthesis and in vitro α-glucosidase inhibition of novel coumarin-pyridines as potent antidiabetic agents

B. Larijani, M. Faramarzi, M. Adib, 2018 .

New 6-amino-pyrido[2,3-d]pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: A simple and efficient synthesis, α-glucosidase inhibition, molecular modeling and kinetic study.

B. Larijani, M. Faramarzi, M. Adib, 2018, European journal of medicinal chemistry.

Synthesis and Evaluation of 6‐Ethoxy‐2‐mercaptobenzothiazole Scaffolds as Potential α ‐Glucosidase Inhibitors

M. Mahdavi, M. Mohammadi‐Khanaposhtani, F. Rahim, 2022, ChemistrySelect.

Design, Synthesis, and Cholinesterase Inhibition Assay of Coumarin‐3‐carboxamide‐N‐morpholine Hybrids as New Anti‐Alzheimer Agents

B. Larijani, H. Nadri, Alireza Moradi, 2019, Chemistry & biodiversity.

Benzoylquinazolinone derivatives as new potential antidiabetic agents: α‐Glucosidase inhibition, kinetic, and docking studies

B. Larijani, M. Faramarzi, A. Foroumadi, 2020 .

Design and synthesis of 2,4‐dioxochroman‐pyridinium‐phenylacetamide derivatives as new anti‐Alzheimer agents: in vitro and in silico studies

B. Larijani, H. Nadri, M. Mahdavi, 2020 .

New benzyl pyridinium derivatives bearing 2,4-dioxochroman moiety as potent agents for treatment of Alzheimer's disease: Design, synthesis, biological evaluation, and docking study.

B. Larijani, H. Nadri, M. Mahdavi, 2019, Bioorganic chemistry.

Design, synthesis, characterization, enzymatic inhibition evaluations, and docking study of novel quinazolinone derivatives.

I. Gulcin, B. Larijani, H. Rastegar, 2020, International journal of biological macromolecules.

Biology‐Oriented Drug Synthesis (BIODS) Approach towards Synthesis of Ciprofloxacin‐Dithiocarbamate Hybrids and Their Antibacterial Potential both in Vitro and in Silico

B. Larijani, M. Amini, M. Faramarzi, 2018, Chemistry & biodiversity.

Pyrano[3,2-c]quinoline Derivatives as New Class of α-glucosidase Inhibitors to Treat Type 2 Diabetes: Synthesis, in vitro Biological Evaluation and Kinetic Study.

B. Larijani, M. Faramarzi, M. Mahdavi, 2019, Medicinal chemistry (Shariqah (United Arab Emirates)).

Design, Synthesis, Biological Evaluation, and Docking Study of Acetylcholinesterase Inhibitors: New Acridone‐1,2,4‐oxadiazole‐1,2,3‐triazole Hybrids

A. Shafiee, A. Foroumadi, M. Mahdavi, 2015, Chemical biology & drug design.

Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.

B. Larijani, Roghayeh Pourbagher, M. Faramarzi, 2019, Bioorganic chemistry.

Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.

B. Larijani, M. Faramarzi, S. Bahadorikhalili, 2018, Bioorganic chemistry.

Design, Synthesis, in Vitro, and in Silico Evaluation of N‐Phenylacetamide‐Oxindole‐Thiosemicarbazide Hybrids as New Potential Tyrosinase Inhibitors

B. Larijani, M. Mahdavi, M. Mohammadi‐Khanaposhtani, 2022, Chemistry & biodiversity.

Design, synthesis, in vitro, and in silico enzymatic evaluations of thieno[2,3-b]quinoline-hydrazones as novel inhibitors for α-glucosidase.

M. Mahdavi, M. Mohammadi‐Khanaposhtani, M. Amanlou, 2022, Bioorganic chemistry.

New 4‐phenylpiperazine‐carbodithioate‐N‐phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α‐glucosidase enzymes

B. Larijani, H. Adibi, P. Taslimi, 2022, Archiv der Pharmazie.

Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies

B. Larijani, H. Rastegar, M. Faramarzi, 2020, Molecular Diversity.

A new series of Schiff base derivatives bearing 1,2,3‐triazole: Design, synthesis, molecular docking, and α‐glucosidase inhibition

B. Larijani, E. Nasli-Esfahani, M. Faramarzi, 2019, Archiv der Pharmazie.

Design and synthesis of new fused carbazole-imidazole derivatives as anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and in silico studies.

B. Larijani, A. Moghadamnia, M. Faramarzi, 2019, Bioorganic & medicinal chemistry letters.

α-Glucosidase and α-amylase inhibition, molecular modeling and pharmacokinetic studies of new quinazolinone-1,2,3-triazole-acetamide derivatives

B. Larijani, Roghayeh Pourbagher, M. Faramarzi, 2021 .

α-Glucosidase and α-amylase inhibition, molecular modeling and pharmacokinetic studies of new quinazolinone-1,2,3-triazole-acetamide derivatives

Roghayeh Pourbagher, M. Faramarzi, S. Bahadorikhalili, 2021, Medicinal Chemistry Research.

2,4-Dioxochroman Moiety Linked to 1,2,3-triazole Derivatives as Novel α-glucosidase Inhibitors: Synthesis, In vitro Biological Evaluation, and Docking Study

B. Larijani, M. Faramarzi, M. Mahdavi, 2020 .

Design, synthesis, in vitro cytotoxic activity evaluation, and apoptosis-induction study of new 9(10H)-acridinone-1,2,3-triazoles

A. Shafiee, A. Foroumadi, M. Mahdavi, 2015, Molecular Diversity.

Synthesis and Evaluation of Chroman‐4‐One Linked to N‐Benzyl Pyridinium Derivatives as New Acetylcholinesterase Inhibitors

A. Shafiee, A. Foroumadi, H. Nadri, 2015, Archiv der Pharmazie.

Novel aryl(4-phenylpiperazin-1-yl)methanethione derivatives as new anti-Alzheimer agents: design, synthesis, in vitro and in silico assays

B. Larijani, H. Adibi, M. Mohammadi‐Khanaposhtani, 2022, Journal of Molecular Structure.

Design, synthesis, and evaluation of metronidazole-1,2,3-triazole derivatives as potent urease inhibitors

B. Larijani, M. Mahdavi, M. Mohammadi‐Khanaposhtani, 2021, Chemical Papers.

New 1,2,3‐triazole–(thio)barbituric acid hybrids as urease inhibitors: Design, synthesis, in vitro urease inhibition, docking study, and molecular dynamic simulation

B. Larijani, M. Asgari, M. Mahdavi, 2020, Archiv der Pharmazie.

Dual functional cholinesterase and carbonic anhydrase inhibitors for the treatment of Alzheimer's disease: Design, synthesis, in vitro, and in silico evaluations of coumarin-dihydropyridine derivatives

I. Gulcin, M. Adib, M. Mohammadi‐Khanaposhtani, 2023, Journal of Molecular Structure.

Potent acetylcholinesterase inhibitors: design, synthesis, biological evaluation, and docking study of acridone linked to 1,2,3-triazole derivatives.

A. Shafiee, A. Foroumadi, M. Mahdavi, 2015, European journal of medicinal chemistry.

Design, Synthesis, Molecular Docking, and Cholinesterase Inhibitory Potential of Phthalimide‐Dithiocarbamate Hybrids as New Agents for Treatment of Alzheimer's Disease

B. Larijani, N. Edraki, H. Nadri, 2019, Chemistry & biodiversity.

Design, synthesis, α-glucosidase inhibition, pharmacokinetic, and cytotoxic studies of new indole-carbohydrazide-phenoxy-N-phenylacetamide derivatives.

I. Gülçin, M. Mohammadi‐Khanaposhtani, H. Hamedifar, 2023, Archiv der Pharmazie.

Design, Synthesis and Cytotoxicity of Novel Coumarin-1,2,3-triazole-1,2,4- Oxadiazole Hybrids as Potent Anti-breast Cancer Agents

M. Mahdavi, M. Mohammadi‐Khanaposhtani, M. Safavi, 2019, Letters in Drug Design & Discovery.

4-Oxobenzo[d]1,2,3-triazin-pyridinium-phenylacetamide derivatives as new anti-Alzheimer agents: design, synthesis, in vitro evaluation, molecular modeling, and molecular dynamic study

B. Larijani, A. Ramazani, H. Adibi, 2020, Structural Chemistry.

Novel fused 1,2,3-triazolo-benzodiazepine derivatives as potent anticonvulsant agents: design, synthesis, in vivo, and in silico evaluations

Jahan B. Ghasemi, B. Larijani, M. Mahdavi, 2019, Molecular Diversity.

Design, synthesis, and biological evaluation of novel 4-oxobenzo[d]1,2,3-triazin-benzylpyridinum derivatives as potent anti-Alzheimer agents.

B. Larijani, A. Ramazani, H. Nadri, 2019, Bioorganic & medicinal chemistry.

Design and synthesis of new N-thioacylated ciprofloxacin derivatives as urease inhibitors with potential antibacterial activity

B. Larijani, A. Iraji, M. Mahdavi, 2022, Scientific Reports.

Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Sojib Bin Zaman, Dan J Stein, Ireneous N. Soyiri, 2017, The Lancet. Neurology.

Indole-carbohydrazide linked phenoxy-1,2,3-triazole-N-phenylacetamide derivatives as potent α-glucosidase inhibitors: design, synthesis, in vitro α-glucosidase inhibition, and computational studies

M. Faramarzi, A. Asadipour, M. Mohammadi‐Khanaposhtani, 2023, BMC Chemistry.

Synthesis, α‐glucosidase Inhibition, in silico Pharmacokinetic, and Docking Studies Of Thieno[2,3‐b]Quinoline‐Acetamide Derivatives as New Anti‐Diabetic Agents

H. Rastegar, M. Faramarzi, M. Mahdavi, 2022, ChemistrySelect.

Design and synthesis of new imidazo[1,2-b]pyrazole derivatives, in vitro α-glucosidase inhibition, kinetic and docking studies

B. Larijani, H. Rastegar, A. Moghadamnia, 2019, Molecular Diversity.

Discovery of novel 4,5-diphenyl-imidazol-α-aminophosphonate hybrids as promising anti-diabetic agents: Design, synthesis, in vitro, and in silico enzymatic studies.

M. Mohammadi‐Khanaposhtani, Ali Moazzam, B. Larijani, 2023, Bioorganic chemistry.

Pyrano[2,3-b]chromone derivatives as novel dual inhibitors of α-glucosidase and α-amylase: Design, synthesis, biological evaluation, and in silico studies.

M. Mohammadi‐Khanaposhtani, B. Larijani, Ensieh Nasli Esfahani, 2024, Bioorganic chemistry.

Synthesis of the new tri-amide derivatives as novel α-glucosidase inhibitors by Ugi four-component reaction

B. Larijani, M. Faramarzi, M. Mahdavi, 2020 .

Hybridization of the effective pharmacophores for treatment of epilepsy: design, synthesis, in vivo anticonvulsant activity, and in silico studies of phenoxyphenyl-1,3,4-oxadiazole-thio-N-phenylacetamid hybrids

M. Mohammadi‐Khanaposhtani, N. Ahangar, B. Larijani, 2023, BMC Chemistry.

New 4,5-diphenylimidazole-acetamide-1,2,3-triazole hybrids as potent α-glucosidase inhibitors: synthesis, in vitro and in silico enzymatic and toxicity evaluations

Reza Ghadimi, B. Larijani, A. Moghadamnia, 2021, Monatshefte für Chemie - Chemical Monthly.